Regulation of Macrophage Activation by House Dust Mite
Project Number5I01BX001850-09
Contact PI/Project LeaderKEEGAN, ACHSAH D.
Awardee OrganizationBALTIMORE VA MEDICAL CENTER
Description
Abstract Text
United States (US) soldiers who have served in Iraq show an increased risk for allergic rhinitis and
asthma; soldiers deployed in the Persian Gulf had twice the risk of developing allergic rhinitis as compared to
homeland stationed personnel and 1.6 times the risk of developing asthma. Furthermore, the diagnosis of
asthma with symptoms after the age of 12 years is an exclusion criterion for military enlistment. While the rea-
son for the increased risk for allergic inflammatory diseases has not been established, exposure to high levels
of dust and other inhaled particles is thought to be the most likely explanation. The ubiquitous environmental
allergen, house dust mite (HDM), was found in high levels in the tents of soldiers serving in Iraq and is known
to be a major inducer of asthma. It has been estimated that between 50-80% of rhinitis and asthma is due to
HDM. However, the mechanisms by which HDM induces and exacerbates asthma are not fully understood.
HDM and many other inhaled particulates contain stimulatory structures we have termed allergen-as-
sociated molecular patterns (AAMPs) that engage and stimulate innate pattern recognition receptors (PRR).
While others have studied the effects of HDM on epithelial and dendritic cells, we have found that HDM directly
activates the macrophage (Mφ) - a cell that is central in the innate immune system and found in abundance in
the lungs and airways. HDM stimulates Mφs to induce the expression of IFNβ and several genes that are char-
acteristic of alternatively-activated Mφs (also termed M2 Mφs), including chitinase family members. We identi-
fied a novel pathway between the induction of IFNβ and caspase 11 that controls chitinase gene expression
and Mφ morphology without inducing high levels of IL-1β or pyroptosis. Furthermore, our preliminary data
show that: (i) HDM stimulates an increase in caspase 11 protein and enzyme activity in a TLR4-independent
manner; (ii) caspase 11 is required for chitinase gene expression and optimal IFNβ induced by HDM in vitro;
(iii) HDM induces a dramatic change in Mφ size and shape with pronounced changes in actin dynamics, {a
response replicated by dust samples from Camp Victory, Iraq; (iv) HDM stimulates expression of protein spe-
cies indicative of autophagy-related processes, such as LC-3 lipidation, without degradative flux;} and (v) we
observed similar HDM-induced changes in human primary Mφs. Thus, our overall goal in this renewal proposal
is to characterize the mechanism by which the non-canonical caspase 11 pathway controls Mφ phenotype and
thus HDM-induced asthma. An understanding of this process is clinically important since human asthmatics
have elevated numbers of M2, as well as increased amounts of chitinase proteins in their blood and airways-
especially during asthma exacerbations. Furthermore, we have shown that M2 initiate and amplify the symp-
toms of asthma in a mouse model.
The central hypothesis to be tested is that the caspase 11 pathway regulates the expression of a sub-
set of M2 genes in Mφs and controls Mφ morphology and migration by regulating actin dynamics critical for
phagolysome and autophagosome fusion, thereby enhancing allergy and asthma. The specific aims designed
to test this hypothesis are: 1) to characterize the role of caspase 11 in regulating HDM-induced changes in Mφ
phenotype and allergic lung inflammation, 2) to delineate the contribution of caspase 11 and autophagic ma-
chinery to the regulation of actin dynamics and Mφ motility induced by HDM, and 3) to validate HDM-induced
responses in human Mφs and {compare responses in Mφs from from asthmatics and control subjects.}
The anticipated outcome of our research is that it will delineate the signaling pathways activated by the
ubiquitous environmental allergen HDM that drive expression of M2 genes and Mφ function. This increase in
knowledge will have benefit for Veterans and the nation because these pathways will likely lead to the identifi-
cation of new targets for the control of HDM-induced allergic rhinitis and asthma.
Public Health Relevance Statement
The number of people in the United States (US) with asthma has dramatically increased over the past 40
years. Unfortunately, diagnosis of asthma with symptoms after the age of 12 years is an exclusion criterion
for military enlistment. Furthermore, US soldiers who have served in Iraq show an increased risk for allergic
rhinitis and asthma. Soldiers deployed in the Persian Gulf had twice the risk of developing allergic rhinitis as
compared to homeland stationed personnel and 1.6 times the risk of developing asthma. Exposure to high
levels of dust and other inhaled particulates is thought to explain the increased risk. The ubiquitous
environmental allergen, house dust mite (HDM), was found in high levels in the tents of soldiers serving in
Iraq and is known to be a major inducer of asthma. Our research project will analyze how house dust mite
controls the differentiation of macrophages and enhances the symptoms of asthma. Thus, our proposed
studies have significant potential to identify novel asthma targets of benefit to Veterans and the nation.
No Sub Projects information available for 5I01BX001850-09
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5I01BX001850-09
Patents
No Patents information available for 5I01BX001850-09
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5I01BX001850-09
Clinical Studies
No Clinical Studies information available for 5I01BX001850-09
News and More
Related News Releases
No news release information available for 5I01BX001850-09
History
No Historical information available for 5I01BX001850-09
Similar Projects
No Similar Projects information available for 5I01BX001850-09